Originally published December 28, 2007 at 12:00 AM | Page modified December 28, 2007 at 12:35 AM
Biotech finalizes cancer drug purchase
In a bid to once again become a biotech company with marketed products, Cell Therapeutics said Thursday it completed its purchase of U.S. rights to the cancer...
Seattle Times business reporter
In a bid to once again become a biotech company with marketed products, Cell Therapeutics said Thursday it completed its purchase of U.S. rights to the cancer drug Zevalin for $10 million.
The therapy is now approved only for treating a common form of blood cancer called relapsed indolent non-Hodgkins lymphoma.
The Seattle biotech will pay an additional $20 million to Biogen-Idec, the therapy's developer, if the U.S. Food and Drug Administration approves it for certain other non-Hodgkins lymphoma applications. Cell Therapeutics will also pay sales royalties until at least December 2015, a statement said.
Zevalin, which in 2006 had U.S. sales of $16.4 million, uses antibodies to deliver radiation directly to cancer cells.
Despite promising data about its effectiveness, oncologists prescribe Zevalin to fewer than 1,000 U.S. patients annually because it must be administered in institutions able to deal with radiation, said Cell Therapeutics Chief Executive James Bianco.
Cell Therapeutics plans an educational and marketing blitz to persuade doctors to adopt the therapy. If it succeeds, Zevalin profits could pay for the development of the company's other products, Bianco said.
"If this product does 50 million or 60 million [dollars] a year — that could fund our entire operations," he said.
Cell Therapeutics has had no commercial products since it sold off Trisenox in 2005. The federal government accused Cell Therapeutics of promoting the drug for unapproved uses, a claim that the company settled earlier this year by paying $10.5 million.
The company now plans to concentrate on growing Zevalin's market share and getting its two leading drug candidates, Xyotax and Pixantrone, to market. Last August, Cell Therapeutics said that it had run up $1 billion in losses since its inception 16 years ago.
Ángel González: 206-515-5644 or agonzalez@seattletimes.com
Copyright © 2007 The Seattle Times Company
Plasma and LCD beware; OLED screens ready to go mainstream
Despite latest uptick, second half of year doesn't look that promising
Q&A : Right cable can work with old camcorder
Summer gas prices should stay put unless ...
Homebodies fuel boob-tube boomlet

Tribal Fireworks Rivalry
The Fourth of July marks a long-standing fireworks rivalry between two clans of a Native-American family in Suquamish.
Entertainment | Top Video | World | Offbeat Video | Sci-Tech
shopping

events for Saturday, Jul. 4th
- Nordstrom Men's Half-Yearly Sale
- Emery's Garden Pink Flamingo Sale
- Darrington Open Air Market
- Karan Dannenberg Clothier Progressive...
editors' picks
More shopping guides- Palin links resignation to 'higher calling'
- Yakima teacher reprimanded for sending 5-year-old student home with bag of feces in backpack
- Plasma and LCD beware; OLED screens ready to go mainstream
- 6 jurors swear a cop's wife swayed panel in Kent civil rights case
- Fire sends service providers scrambling
- Going to Gas Works Park? Good luck
- Fourth of July festivals and fireworks in Seattle, the suburbs and beyond
- Woman accuses Sounders FC player Nate Jaqua of sexual assault, seeks more than $10 million
- More than 1 million seek tix for Jackson memorial
- Rob Johnson's double in 11th powers Mariners past Red Sox, 7-6
- Palin resigning as Alaska governor
748 - Seattle Mariners at Boston Red Sox: 07/04 game thread
244 - Woman accuses Sounders FC player Nate Jaqua of sexual assault, seeks more than $10 million
99 - Reports: NKorean missile arrives at launch site
98 - Palin's Declaration of Independence
73 - Mariners score unlikely win over Red Sox in battle of bullpens
58 - Rob Johnson ties a club record as Mariners win 7-6 in 11 innings
54 - Hatred for the NBA runs deep, but don't take it out on the players
53 - Former NFL MVP McNair killed
40 - Man pistol-whipped after argument at nightclub
40
- Plasma and LCD beware; OLED screens ready to go mainstream
- Going to Gas Works Park? Good luck
- Liven up Fremont's attempt to break a world record for a 'zombie walk'
- Merchant Marine veterans fight for recognition
- Lynnwood's City Bank gets tighter scrutiny
- Yakima teacher reprimanded for sending 5-year-old student home with bag of feces in backpack
- Retail Report | Pet-supply shops grow while other retailers fade
- Palin links resignation to 'higher calling'
- Fire sends service providers scrambling
- Oregon woman obsessed with rabbits back in jail
